Burberry Group shed £243M in market capitalization over seven trading sessions through Wednesday, closing at 914p per share, as UBS downgraded expectations for near-term earnings revisions ahead of the company's May 15th results. The move marks the first significant analyst skepticism since Joshua Schulman's appointment as CEO in July 2024, when shares rallied 41% on operational restructuring announcements.
UBS analyst Zuzanna Pusz wrote that while the luxury house's cost reduction programme remains on track—targeting £40M in annualized savings by fiscal 2026—revenue stabilization will take longer than equity markets priced in during Q4 2024. Burberry reported comparable store sales down 4% in the thirteen weeks ending December 28th, an improvement from the 22% decline in the prior quarter, but still negative in absolute terms. Pusz noted that consensus expectations for flat comparable sales by Q2 fiscal 2026 assume an acceleration the company has not yet demonstrated in any major market outside Japan.
The upgrade question matters because Burberry's current 9.2x forward EBITDA multiple depends on operating margin expansion from 8.1% in fiscal 2024 to an estimated 12.5% by fiscal 2027. That path requires both cost discipline and positive operating leverage, which breaks down if revenue remains pressured. The company's two-year repositioning plan under Schulman includes reducing SKU count by 30%, exiting wholesale relationships that dilute brand equity, and refocusing on outerwear and scarves at higher price points. None of those initiatives deliver revenue in the first twelve months. Meanwhile, Chinese luxury consumption remains 7% below pre-COVID levels in real terms, and Burberry generates 27% of sales in Greater China.
Family offices and long-duration allocators should watch three specific data points in the May report: (1) gross margin trajectory, which needs to print above 71.5% to validate pricing power in the new product assortment; (2) inventory turns, which stood at 2.1x in the prior quarter and need to reach 2.6x to fund the buyback program suspended in November; (3) guidance language on fiscal 2026 operating profit, where any range below £400M will trigger another round of estimate cuts. UBS expects £385M, implying a 15% downside to the current consensus of £453M.
Burberry's next test arrives May 15th, when the market will learn whether comparable sales inflected positive in Q4 or whether the recovery extends into a third year.